DEA and SAMHSA Extend Telemedicine Flexibilities for Prescription of Controlled Substances
The Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) have extended the temporary telemedicine flexibilities for prescribing controlled substances through December 31, 2026.
















